AKERO THERAPEUTICS INC's ticker is AKRO and the CUSIP is 00973Y108. A total of 103 filers reported holding AKERO THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 4.79 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $87,370,517 | -3.6% | 2,419,425 | +24.7% | 2.91% | +11.1% |
| Q2 2023 | $90,610,116 | +352.4% | 1,940,675 | +270.7% | 2.62% | +343.8% |
| Q1 2023 | $20,030,067 | +4.3% | 523,525 | +49.4% | 0.59% | +9.6% |
| Q4 2022 | $19,208,770 | +31.2% | 350,525 | -18.5% | 0.54% | +26.8% |
| Q3 2022 | $14,642,000 | +2069.2% | 430,000 | +1860.1% | 0.42% | +4150.0% |
| Q3 2020 | $675,000 | – | 21,938 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Skorpios Trust | 3,271,829 | $125,180,178 | 50.58% |
| COMMODORE CAPITAL LP | 790,000 | $30,225,400 | 4.60% |
| Redmile Group, LLC | 2,044,389 | $78,218,323 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 202,561 | $7,749,984 | 3.20% |
| Ghost Tree Capital, LLC | 275,000 | $10,522,000 | 3.11% |
| Avidity Partners Management LP | 2,447,000 | $93,622,220 | 3.11% |
| Atlas Venture Life Science Advisors, LLC | 594,251 | $22,736,043 | 3.08% |
| Logos Global Management LP | 400,000 | $15,304,000 | 2.19% |
| Yiheng Capital Management, L.P. | 1,125,791 | $43,072,764 | 1.70% |
| Boxer Capital, LLC | 831,495 | $31,813 | 1.56% |